Ki16425
产品编号: DC7179
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Ki16425 (Debio 0719) 是一种亚型选择性,竞争性的 EDG 家族受体拮抗剂,对 LPA1 和 LPA3 的 Ki 值分别为 0.34 μM,0.93 μM。Ki16425 (Debio 0719) 降低 LPA 诱导的 p42/p44 MAPK 激活。Ki16425 还可抑制 LPA 诱导的 HEK293A 细胞中 YAP/TAZ 的去磷酸化。
Cas No.: |
355025-24-0 |
名称: |
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl)-3-methylisoxazol-5-yl)benzylthio)propanoicacid |
别名: |
Ki-16425; Ki 16425 |
SMILES: |
CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)O |
分子式: |
C23H23ClN2O5S |
分子量: |
474.96 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
Kil6425 preferentially inhibits LPA1- and LPA3-mediated responses but has only a moderate effect on LPA2. Ki16425 inhibits the LPA-induced Ca(2+) response in THP-1 cells, 3T3 fibroblasts, and A431 cells, but had only a marginal effect in PC-12 cells and H |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
COA
LOT NO. |
DOWNLOAD |
|
|
2018-0101 |
|
询盘